Drug Shortage Report for ACT MELOXICAM
| Report ID | 102935 |
| Drug Identification Number | 02250012 |
| Brand name | ACT MELOXICAM |
| Common or Proper name | MELOXICAM 7.5MG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MELOXICAM |
| Strength(s) | 7.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | M01AC |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-08 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-01-09 |
| Company comments | item is To Be Disc |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-01-09 | French | Compare |
| v1 | 2020-01-09 | English | Compare |
Showing 1 to 2 of 2